针对COVID-19的核囊向性疫苗的概述
Alexandra Rak1, Irina Isakova-Sivak1, Larisa Rudenko1
1Department of Virology, Institute of Experimental Medicine, St. Petersburg 197022, Russia.
Vaccines
|December 23, 2023
概括
核体 (N) 蛋白质疫苗显示出由于N蛋白质的存在,对广泛的COVID-19保护有希望.
科学领域:
- 病毒学和免疫学 病毒学和免疫学
- 疫苗开发 疫苗开发
背景情况:
- 导致COVID-19的SARS-CoV-2病毒是高度可变的,影响疫苗的疗效.
- 尖 (S) 蛋白疫苗对新出现的SARS-CoV-2变种的有效性较低,原因是抗原的变异性.
- 核体 (N) 蛋白是一种更保守的SARS-CoV-2抗原,使其成为广谱疫苗的潜在目标.
研究的目的:
- 总结关于基于核体 (N) 蛋白质的COVID-19疫苗的当前数据.
- 评估N蛋白疫苗对抗SARS-CoV-2变种的广泛保护的潜力和局限性.
主要方法:
- 对基于N的COVID-19疫苗现有科学数据的审查.
- 对N蛋白序列突变及其对免疫性影响的分析.
- 考虑动物挑战模型和N蛋白疫苗临床试验结果.
主要成果:
- 为了预防COVID-19,正在测试N蛋白疫苗.
- 尽管被保存,N蛋白序列已经积累了影响T细胞表位的突变.
- 最近的SARS-CoV-2变种可能表现出改变的N蛋白抗原性.
结论:
- 核体 (N) 蛋白质是开发广泛保护性COVID-19疫苗的有希望的目标.
- 在N蛋白序列中的突变可以降低其抗原性和保护功效.
- 由于N蛋白的抗原性不断变化,因此在制造交叉反应性疫苗方面面临着挑战.
更多相关视频
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.6K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
2.6K
相关概念视频
Viral Structure
62.3K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.3K
Conjugated Proteins
18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K
Vaccinations
44.5K
Overview
44.5K
Immune Response Against Viral Pathogens
789
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
789
Cancer Vaccines
370
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
370
What are Viruses?
115.0K
Overview
115.0K
